Influenza

A trio of experts will discuss how to battle dual epidemics.

The ACP says that staying up to date on vaccinations is more important than ever.

This is the third test approved for the detection and differentiation of the viruses that cause COVID-19 and the flu.

How to keep your patients and your staff healthy

Influenza hospitalizes nearly 1 million individuals each year and kills over 80,000. It's no surprise that most Americans worry about catching it. 

Public health officials are hopeful a record number of flu vaccines can help stave off epidemic levels.

Antibodies that were previously overlooked may hold the key to a better flu vaccine.

New research shows that a ketogenic diet may help activate new immune responses that can help fight influenza A.

University of Georgia researchers secured a multi-million grant to create a better flu vaccine.

President Donald Trump offered his support for flu vaccines and promised to promote additional research on seasonal flu, but will it help?

Experts say it’s too early to predict the severity of the flu season, or how effective the vaccine will be

The flu vaccine can help protect against more than just the flu. A new study reveals extended benefits, especially for the elderly.

Fluzone High-Dose Quadrivalent has been approved for use in patients over 65 to help prevent A and B strains of influenza.

Everyone over the age of six months and especially pregnant women are urged to get flu shots

H1N1 is the most prevalent flu virus circulating this year, resulting in a less severe flu season overall than last year when H3N2 was predominant.

A new report links early treatment of influenza A/H3N2 with the drug to a 30% decrease in mortality.

Researchers have found that the microbiome in the respiratory tract contributes to how susceptible we each are to the flu. Work is underway to use this data to create a preventive tool

A new study reveals that llama antibodies may be effective in offering protection against numerous flu strains in a single vaccine

A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.

A new vaccine in development could provide increased flu protection for seniors.

It’s too early yet to say whether last year’s devastating flu season will motivate more patients to receive flu shots, but so far it looks like a good year for the vaccine.

NasoVax is still in the development stages but may eventually provide an option for patients who are immunocompromised.

A new one-dose antiviral-the first treatment approved to fight the flu in 20 years-will be available to clinicians this flu season.

The intranasal vaccine is back, and changes have been made to the viral composition of this year’s vaccine.